7ypn
From Proteopedia
(Difference between revisions)
m (Protected "7ypn" [edit=sysop:move=sysop]) |
|||
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Crystal structure of transaminase CC1012 mutant M9 complexed with PLP== | |
| + | <StructureSection load='7ypn' size='340' side='right'caption='[[7ypn]], [[Resolution|resolution]] 2.05Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[7ypn]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Caulobacter_sp._D5 Caulobacter sp. D5]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=7YPN OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=7YPN FirstGlance]. <br> | ||
| + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.049Å</td></tr> | ||
| + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene>, <scene name='pdbligand=PLP:PYRIDOXAL-5-PHOSPHATE'>PLP</scene></td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=7ypn FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=7ypn OCA], [https://pdbe.org/7ypn PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=7ypn RCSB], [https://www.ebi.ac.uk/pdbsum/7ypn PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=7ypn ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [https://www.uniprot.org/uniprot/A0A318BC23_9CAUL A0A318BC23_9CAUL] | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | omega-Transaminases (omega-TAs) show considerable potential for the synthesis of chiral amines. However, their low catalytic efficiency towards bulky substrates limits their application, and complicated catalytic mechanisms prevent precise enzyme design. Herein, we address this challenge using a mechanism-guided computational enzyme design strategy by reprograming the transition and ground states in key reaction steps. The common features among the three high-energy-barrier steps responsible for the low catalytic efficiency were revealed using quantum mechanics (QM). Five key residues were simultaneously tailored to stabilize the rate-limiting transition state with the aid of the Rosetta design. The 14 top-ranked variants showed 16.9-143-fold improved catalytic activity. The catalytic efficiency of the best variant, M9 (Q25F/M60W/W64F/I266A), was significantly increased, with a 1660-fold increase in k(cat) /K(m) and a 1.5-26.8-fold increase in turnover number (TON) towards various indanone derivatives. | ||
| - | + | Mechanism-Guided Computational Design of omega-Transaminase by Reprograming of High-Energy-Barrier Steps.,Yang L, Zhang K, Xu M, Xie Y, Meng X, Wang H, Wei D Angew Chem Int Ed Engl. 2022 Dec 23;61(52):e202212555. doi: , 10.1002/anie.202212555. Epub 2022 Nov 23. PMID:36300723<ref>PMID:36300723</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | [[Category: | + | </div> |
| - | [[Category: | + | <div class="pdbe-citations 7ypn" style="background-color:#fffaf0;"></div> |
| - | [[Category: Wang | + | == References == |
| - | [[Category: Wei | + | <references/> |
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Caulobacter sp. D5]] | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Wang H]] | ||
| + | [[Category: Wei D]] | ||
| + | [[Category: Yang L]] | ||
Current revision
Crystal structure of transaminase CC1012 mutant M9 complexed with PLP
| |||||||||||
